#GranulesIndia #NIPER #PharmaInnovation #SustainablePharma #GreenScience #EcoFriendlyManufacturing #DrugDevelopment #HealingLivesResponsibly #PharmaResearch
Driving Green Technologies in Pharmaceutical Manufacturing to Shape a Healthier and Responsible Future
Mohali – In a significant stride towards sustainable healthcare and eco-friendly industrial practices, Granules India Limited, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, inaugurated the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).
This new Centre of Excellence marks a transformative collaboration between industry and academia, aiming to foster research, innovation, and knowledge-sharing to address pressing challenges in pharmaceutical manufacturing while ensuring environmental responsibility.
Granules’ Vision of Healing Lives Responsibly
Granules India, a leading pharmaceutical company with global reach, has consistently emphasized its commitment to innovation and sustainability. The inauguration of CCE-ISPD is a natural extension of its vision to integrate green science with responsible business practices.
Speaking at the launch, Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited, underlined the importance of aligning innovation with sustainability:
“At Granules, we believe that innovation and sustainability go hand in hand. Guided by our purpose of Healing Lives Responsibly through Pioneering Green Science, this initiative reflects our commitment to shaping a healthier, more sustainable future—not just for our stakeholders but for communities and ecosystems that sustain us.”
This vision is reflected in the Centre’s mandate of developing eco-friendly solutions in drug product manufacturing, helping reduce carbon footprints, and setting global benchmarks for sustainable practices in the pharmaceutical sector.
Academic-Industry Partnership for Sustainable Growth
The partnership with NIPER Mohali, India’s premier pharmaceutical education and research institute, brings academic expertise together with Granules India’s industrial leadership.
Prof. Dulal Panda, Director of NIPER S.A.S Nagar, emphasized that the collaboration was a milestone in bridging industry and academia to deliver real-world solutions:
“This collaboration brings academia and industry together to solve practical challenges. By focusing on sustainable practices, we can deliver innovative solutions that benefit both the environment and patients worldwide.”
The Centre will operate under the academic supervision of Dr. Arvind K. Bansal, Professor, Department of Pharmaceutics, who will lead research initiatives and guide students and scholars in exploring next-generation green pharma technologies.
Core Focus Areas of the Centre
CCE-ISPD will focus on multiple key areas, combining industrial applicability with environmental stewardship:
-
Green Manufacturing: Reducing the carbon footprint in formulation production and Active Pharmaceutical Ingredient (API)–formulation interface.
-
Sustainable Technologies: Development of scalable and eco-friendly pharma technologies with long-term impact.
-
Intellectual Property Creation: Encouraging patents and IP around sustainable pharmaceutical processes.
-
Skill Development: Training the next generation of scientists in sustainable research methodologies.
-
Industry Benchmarks: Establishing new standards for responsible and green manufacturing in pharma.
Impact on Students, Researchers, and Industry
For students and researchers, the Centre will provide access to state-of-the-art labs, modern infrastructure, and industry mentorship. This will empower young minds to work on cutting-edge sustainable drug development projects and explore entrepreneurship in green technologies.
For the pharmaceutical industry, CCE-ISPD is expected to serve as a hub of innovation, providing scalable, cost-effective, and eco-friendly solutions that can be adopted by pharma companies in India and abroad.
The initiative also strengthens India’s global positioning as a hub for sustainable pharmaceutical development, supporting the nation’s goal of becoming a leader not only in generic drug manufacturing but also in responsible, green innovation.
CSR with a Larger Purpose
The establishment of the Centre is part of Granules India’s Corporate Social Responsibility (CSR) vision, which focuses on healthcare, education, and sustainability. Unlike traditional CSR projects, this initiative takes a research-driven approach to deliver long-term impact on both society and the environment.
By creating a research platform that benefits academia, industry, and society, Granules India has showcased how CSR can be aligned with innovation and sustainability goals, creating value beyond immediate philanthropy.
Paving the Way for a Greener Future in Pharma
The launch of CCE-ISPD comes at a crucial time when the pharmaceutical industry is under global scrutiny for its carbon footprint, supply chain dependencies, and impact on public health systems. With rising demand for medicines worldwide, there is also a growing need for eco-friendly, energy-efficient, and waste-reducing technologies.
By pioneering this green initiative, Granules India and NIPER are not only responding to these challenges but also setting a precedent for the entire pharma industry to rethink its growth strategies through the lens of sustainability.
The Centre will also work towards creating global partnerships, engaging with international research bodies, and contributing to India’s goal of becoming a leader in sustainable and ethical pharmaceutical practices.
Conclusion
The inauguration of the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD) represents a historic milestone in India’s pharmaceutical journey. By combining industrial vision, academic strength, and sustainable innovation, the initiative is poised to redefine the way pharmaceuticals are developed and manufactured in the country.
This collaboration reaffirms that long-term success in the healthcare sector is deeply intertwined with ethical responsibility and environmental stewardship. As India positions itself as a global healthcare leader, initiatives like CCE-ISPD will ensure that its growth is responsible, sustainable, and impactful for generations to come.
Hashtags
#GranulesIndia #NIPER #PharmaInnovation #SustainablePharma #GreenScience #EcoFriendlyManufacturing #DrugDevelopment #HealingLivesResponsibly #PharmaResearch #HealthcareForFuture #GreenPharma #SustainableHealthcare #CSRInitiative #PharmaSustainability #IndiaInnovation #PharmaLeadership
